Keymed Biosciences Inc. (2162.HK) - Stock Prices, Stock Peers & Analysis

Home
2162.HK

Company Name	Keymed Biosciences Inc.
Symbol	2162.HK
Currency	HKD
Price	44.7
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	12,319,320,000
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	26.6 - 57.65
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Bo Chen
Website	https://www.keymedbio.com

An error occurred while fetching data.

About Keymed Biosciences Inc.

Keymed Biosciences Inc., a biotechnology company, engages in the research and development of biological therapies for the treatment of autoimmunity and oncology diseases. Its lead product candidate is CM310 for the treatment of moderate to severe atopic dermatitis (AD), asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), and chronic obstructive pulmonary